| Issue |
BIO Web Conf.
Volume 229, 2026
The 3rd International Conference of Advanced Veterinary Science and Technologies for Sustainable Development (3rd ICAVESS 2025)
|
|
|---|---|---|
| Article Number | 01005 | |
| Number of page(s) | 9 | |
| Section | Advancing Animal Health | |
| DOI | https://doi.org/10.1051/bioconf/202622901005 | |
| Published online | 12 March 2026 | |
Case Report: Uses of Nigella sativa in A Cat with Feline Panleukopenia Virus Infection
1 Veterinary Clinical Clerkship Student, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 Departement of Internal Medicine, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
* Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Feline panleukopenia virus (FPV) is a pathogenic Parvoviridae virus that causes high mortality and morbidity, characterized by leukopenia (<2,000 cells/µL). Nigella sativa (black cumin), is a herb with bioactive compound Thymoquinone which recognized for its immunomodulatory and antiviral characteristics. The ability to enhance immune function and leukocyte counts in animal models has been reported; however, its application in cats with FPV and leukopenia remains unreported. We report a case of a 1-year-old, 2.8 kg, unvaccinated domestic male cat presenting anorexia, vomiting, fever, hypersalivation, and history of exposure to FPV-positive cats. The cat tested positive for FPV by rapid antigen assay and showed severe leukopenia (450 cells/µL). Supported therapy was given, combined with oral administration of Black cumin extract with dosages modified from other research on Mus Musculus. Following the treatment, progressing improvement in total leukocyte count and recovery of the differential leukocyte profile were observed. This case suggests that clack cumin extract may have potential as an adjunctive immunomodulatory therapy in cats with FPV, although further controlled studies are required to confirm its efficacy and safety
© The Authors, published by EDP Sciences, 2026
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.

